-
Utilization of Real-World Evidence (RWE) in AMNOG Dossiers Following the 2024 GBA Revision of Module 3 Requirements
Sep 9, 2025, 16:22 PM -
Infective Endocarditis Following FRANCE-TAVI Insights
Sep 9, 2025, 16:22 PM -
Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions
Sep 9, 2025, 16:22 PM -
Rising Polypharmacy Trends and Associated Factors in Chinese Adults With Diabetes: A Population-Based Cohort Study
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) in Duchenne Muscular Dystrophy (DMD): Insights From the DMD-QoL Instrument in the United States (US)
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Linzagolix 200 mg Plus Add-back Therapy (Linzagolix+ABT) for Symptomatic Treatment of Endometriosis
Sep 9, 2025, 16:22 PM -
Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)
Sep 9, 2025, 16:22 PM -
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
The Evolving Role of Pharmacists as Vaccinators in New Zealand and Denmark
Sep 9, 2025, 16:22 PM -
Unraveling the Challenges of Multiplex Cell Culture Technology Using the HTA Core Model
Sep 9, 2025, 16:22 PM -
Uncovering the Cost Landscape of Congenital Heart Disease (CHD) With a Life Course Perspective: A Systematic Review of Healthcare Utilization by Lesion Type and Age
Sep 9, 2025, 16:22 PM -
A Real-World Survey of Healthcare Resource Utilization Treatment Usage and Unmet Need for Hemophilia Patients in Spain
Sep 9, 2025, 16:22 PM -
Weighting the OrPhar-SEFH MCDA Framework for Its Use in Ultrarare Kidney Diseases
Sep 9, 2025, 16:22 PM -
The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access
Sep 9, 2025, 16:22 PM -
Timing Matters: Missed Opportunity to Prevent RSV Cases in Older Adults in Germany: A Markov Model Analysis
Sep 9, 2025, 16:22 PM -
How Do Neurologists Perceive the Organization and Functioning of Care in Their Multiple Sclerosis Units?
Sep 9, 2025, 16:22 PM -
Budget Impact of an Ambulatory Minimally Invasive Surgical Treatment in an Italian Public Hospital
Sep 9, 2025, 16:22 PM -
Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan
Sep 9, 2025, 16:22 PM -
When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glaucoma (OAG)
Sep 9, 2025, 16:22 PM -
Early Access Programs and Pricing and Reimbursement Agreements of Orphan Medicines in Portugal
Sep 9, 2025, 16:22 PM
